Borja Garcia C. P.
- Country
- Spain
- Department
- Pediatria
Research Overview
- A Randomized Controlled Trial Comparing the Efficacy of Umeclidinium Bromide, Fluticasone Furoate, and Vilanterol Versus LABA-LAMA Combination in High-Risk COPD Patients
- Long-term Safety Evaluation of Depemokimab in Adults and Adolescents with Severe Eosinophilic Asthma: An Open-Label Extension Study
Data & Insights
Has run more than one trial at 5 of 82 partner sites.
Specializations
Respiratory Disease Management
This investigator specializes in treating complex respiratory conditions, with particular emphasis on chronic obstructive pulmonary disease (COPD) and various forms of asthma.
- Moderate to severe COPD treatment approaches
- Management of uncontrolled asthma
- Triple therapy interventions
Their work encompasses both standard therapeutic approaches and innovative treatment strategies for respiratory conditions.
Specialized Asthma Care
The investigator has developed expertise in treating specific asthma phenotypes, particularly focusing on eosinophilic asthma and severe asthma variants.
- Eosinophilic phenotype treatment
- Long-term asthma management
- Therapy optimization for uncontrolled cases
Their clinical focus includes both established and emerging therapeutic approaches for difficult-to-treat asthma cases.
Advanced Therapeutic Applications
The investigator works with novel therapeutic agents and biological treatments for respiratory conditions.
- Targeted molecular therapies
- Combination treatment strategies
- Long-term safety assessments
Their practice incorporates evaluation of innovative therapeutic approaches for respiratory disease management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.